Therapeutic Potential of Umbilical Cord Stem Cells for Liver Regeneration

Author(s): Ifrah Anwar, Usman A. Ashfaq*, Zeeshan Shokat.

Journal Name: Current Stem Cell Research & Therapy

Volume 15 , Issue 3 , 2020

Become EABM
Become Reviewer


The liver is a vital organ for life and the only internal organ that is capable of natural regeneration. Although the liver has high regeneration capacity, excessive hepatocyte death can lead to liver failure. Various factors can lead to liver damage including drug abuse, some natural products, alcohol, hepatitis, and autoimmunity. Some models for studying liver injury are APAP-based model, Fas ligand (FasL), D-galactosamine/endotoxin (Gal/ET), Concanavalin A, and carbon tetrachloride-based models. The regeneration of the liver can be carried out using umbilical cord blood stem cells which have various advantages over other stem cell types used in liver transplantation. UCB-derived stem cells lack tumorigenicity, have karyotype stability and high immunomodulatory, low risk of graft versus host disease (GVHD), low risk of transmitting somatic mutations or viral infections, and low immunogenicity. They are readily available and their collection is safe and painless. This review focuses on recent development and modern trends in the use of umbilical cord stem cells for the regeneration of liver fibrosis.

Keywords: Umblical cord, liver fibrosis, regenerative medicine, mesenchymal stem cells, fibrosis models, therapeutic potential.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2020
Page: [219 - 232]
Pages: 14
DOI: 10.2174/1568026620666200220122536
Price: $65

Article Metrics

PDF: 14